TYD vs. CURE
TYD (Direxion Daily 7-10 Year Treasury Bull 3X) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - TYD is a Leveraged Bonds fund tracking the NYSE 7-10 Year Treasury Bond Index, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, TYD returned -5.12%/yr vs 13.49%/yr for CURE. At a correlation of -0.09, they often move in opposite directions. TYD charges 1.09%/yr vs 1.08%/yr for CURE.
Performance
TYD vs. CURE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TYD achieves a -5.80% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, TYD has underperformed CURE with an annualized return of -5.12%, while CURE has yielded a comparatively higher 13.49% annualized return.
TYD
- 1D
- -0.33%
- 1M
- 2.41%
- YTD
- -5.80%
- 6M
- -5.59%
- 1Y
- 0.17%
- 3Y*
- -3.95%
- 5Y*
- -13.19%
- 10Y*
- -5.12%
CURE
- 1D
- -0.55%
- 1M
- 17.48%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 28.51%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
TYD vs. CURE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TYD Direxion Daily 7-10 Year Treasury Bull 3X | -5.80% | 11.68% | -13.89% | -2.87% | -43.32% | -11.36% | 27.62% | 17.88% | 0.76% | 5.64% |
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
Correlation
The correlation between TYD and CURE is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | -0.09 |
The correlation between TYD and CURE shifts across timeframes, from -0.09 (all time) to 0.30 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TYD vs. CURE — Risk / Return Rank
TYD
CURE
TYD vs. CURE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily 7-10 Year Treasury Bull 3X (TYD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TYD | CURE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -1.20 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.13 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | -0.08 | 0.85 | -0.93 |
| Martin ratioReturn relative to average drawdown | -0.20 | 1.94 | -2.14 |
Loading charts...
Drawdowns
TYD vs. CURE - Drawdown Comparison
The maximum TYD drawdown since its inception was -64.28%, smaller than the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for TYD and CURE.
Loading charts...
Drawdown Indicators
| TYD | CURE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.28% | -69.19% | +4.91% |
Max Drawdown (1Y)Largest decline over 1 year | -13.54% | -31.10% | +17.56% |
Max Drawdown (3Y)Largest decline over 3 years | -24.62% | -51.93% | +27.31% |
Max Drawdown (5Y)Largest decline over 5 years | -59.84% | -52.23% | -7.61% |
Max Drawdown (10Y)Largest decline over 10 years | -64.28% | -69.19% | +4.91% |
Current DrawdownCurrent decline from peak | -59.06% | -26.94% | -32.12% |
Average DrawdownAverage peak-to-trough decline | -22.00% | -18.16% | -3.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.30% | 13.71% | -8.41% |
Volatility
TYD vs. CURE - Volatility Comparison
The current volatility for Direxion Daily 7-10 Year Treasury Bull 3X (TYD) is 4.49%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that TYD experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TYD | CURE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.49% | 14.30% | -9.81% |
Volatility (6M)Calculated over the trailing 6-month period | 9.76% | 30.87% | -21.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.86% | 44.32% | -30.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.97% | 43.84% | -20.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.36% | 49.59% | -29.23% |
TYD vs. CURE - Expense Ratio Comparison
TYD has a 1.09% expense ratio, which is higher than CURE's 1.08% expense ratio.
Dividends
TYD vs. CURE - Dividend Comparison
TYD's dividend yield for the trailing twelve months is around 3.22%, more than CURE's 1.16% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
TYD Direxion Daily 7-10 Year Treasury Bull 3X | 3.22% | 2.97% | 3.10% | 2.71% | 0.55% | 0.00% | 9.80% | 0.92% | 1.10% | 0.01% | 6.84% | 1.65% |
Frequently Asked Questions
TYD and CURE have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.30%) compared to TYD (4.49%). In terms of maximum drawdown, TYD dropped -64.28% vs CURE's -69.19%.
On 10-year performance, CURE leads with 13.49% vs -5.12% for TYD. On fees, CURE is cheaper at 1.08% per year. On volatility, TYD has been the lower-risk option at 4.49%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.49% return vs -5.12%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 1.08% expense ratio, compared with 1.09% for TYD.
TYD has the higher dividend yield at 3.22%, compared with 1.16% for CURE.
TYD is categorized as Leveraged Bonds, while CURE is Leveraged Equities. TYD tracks NYSE 7-10 Year Treasury Bond Index, while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.09% for TYD and 1.08% for CURE.
CURE currently has the higher Sharpe Ratio (0.60 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TYD and CURE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer